Physician Assistant · Philadelphia, PA
NPI
1750055968
Since 2021
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
833 Chestnut St Ste 1220
Philadelphia, PA, 19107
Phone (800) 321-9999
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
936 services
Medicare patients, 2024
142
Average age 63
Drug cost, 2024
$1.3M
5,402 prescriptions
Company payments, 2025
$949
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond P Reyes was code 99214 (office e&m - established), 454 times for 126 patients. In total Raymond P Reyes billed 936 services in 7 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 454 | 126 | $81.30 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 365 | 107 | $11.23 | $4,101 |
| 99213 Office E&M - Established | Office | 100 | 46 | $49.93 | $4,993 |
By year: 2022 $46K for 753 services; 2023 $47K for 628 services; 2024 $47K for 936 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raymond P Reyes prescribed most often to Medicare patients was Oxycodone Hcl, with 964 prescriptions and refills. In total Raymond P Reyes wrote 5,402 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 964 | 964 | 155 | $23K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 691 | 691 | 119 | $17K |
| Gabapentin Generic | 415 | 440 | 90 | $5,883 |
| Pregabalin Generic | 352 | 362 | 69 | $9,635 |
| Tizanidine Hcl Generic | 212 | 223 | 47 | $1,510 |
| Relistor Methylnaltrexone Bromide | 211 | 217 | 60 | $500K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 209 | 209 | 40 | $4,342 |
| Cyclobenzaprine Hcl Generic | 207 | 209 | 43 | $2,049 |
| Belbuca Buprenorphine Hcl | 207 | 207 | 38 | $186K |
| Meloxicam Generic | 160 | 166 | 31 | $465 |
| Buprenorphine Generic | 146 | 146 | 24 | $40K |
| Xtampza Er Oxycodone Myristate | 138 | 138 | 24 | $62K |
| Morphine Sulfate Er Morphine Sulfate | 135 | 135 | 25 | $3,264 |
| Ztlido Lidocaine | 97 | 107 | 25 | $99K |
| Diclofenac Sodium Generic | 90 | 93 | 24 | $23K |
Brand drugs: 1,053 claims; generic drugs: 4,349 claims; opioid claims: 2,878.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond P Reyes $949 ($949 in general payments such as food, travel and fees) from 10 companies. The largest payer was Boston Scientific Corporation with $359.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 8 | $359 |
| Collegium Pharmaceutical, Inc. COLL | 15 | $176 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 10 | $147 |
| Valinor Pharma, LLC | 4 | $65.52 |
| Azurity Pharmaceuticals, Inc. | 3 | $50.96 |
| Pfizer Inc. PFE | 2 | $45.01 |
| Impel Pharmaceuticals LLC | 2 | $39.02 |
| IBSA Pharma Inc. | 2 | $37.52 |
| Indivior Inc. INDV | 1 | $14.31 |
| Abbvie Inc. ABBV | 1 | $13.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.